Aardvark Therapeutics (AARD)
5.38
-0.35 (6.11%)
Upcoming Events
Latest Headlines
Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); Hub Group, Inc. (NASDAQ: HUBG); and Insulet Corporation (NASDAQ: PODD): G
September 1, 2026 8:25 AM - StreetInsider
Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL);
August 31, 2026 8:45 AM - StreetInsider
Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and Hub Group, Inc. (NASDAQ: HUBG); Grabar Law Of
August 27, 2026 8:51 AM - StreetInsider
Form 4 Aardvark Therapeutics, For: Aug 14 Filed by: Chi Jeffrey
August 21, 2026 7:49 PM - SEC Filing
Form 4 Aardvark Therapeutics, For: Aug 14 Filed by: Graf Susan E
August 21, 2026 7:47 PM - SEC Filing
Form 4 Aardvark Therapeutics, For: Aug 14 Filed by: Baynes Roy D.
August 21, 2026 7:46 PM - SEC Filing
Form 4 Aardvark Therapeutics, For: Aug 14 Filed by: Tong Victor Edward Jr
August 21, 2026 7:45 PM - SEC Filing
Form 8-K Aardvark Therapeutics, For: Aug 14
August 17, 2026 4:10 PM - SEC Filing
Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
August 11, 2026 5:24 PM - StreetInsider
Form 10-Q Aardvark Therapeutics, For: Jun 30
August 11, 2026 5:10 PM - SEC Filing
Form 8-K Aardvark Therapeutics, For: Aug 11
August 11, 2026 5:05 PM - SEC Filing
Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 11, 2026 4:53 PM - Globe NewsWire
Form ARS Aardvark Therapeutics, For: Dec 31
July 10, 2026 4:12 PM - SEC Filing
Form DEF 14A Aardvark Therapeutics, For: Aug 14
July 10, 2026 4:06 PM - SEC Filing
Form PRE 14A Aardvark Therapeutics, For: Aug 14
June 29, 2026 4:06 PM - SEC Filing
Form 8-K Aardvark Therapeutics, For: Jun 10
June 12, 2026 4:06 PM - SEC Filing
Full Article List
